Rang	Name	Position
1	Dr. Joseph K. Belanoff M.D.	Co-Founder, President, CEO & Director
2	Mr. Atabak Mokari	CFO & Treasurer
3	Dr. William Guyer Pharm.D.	Chief Development Officer
4	Mr. Gary Charles Robb J.D.	Chief Business Officer & Secretary
5	Mr. Joseph Douglas Lyon	Chief Technology & Accounting Officer
6	Dr. Hazel Hunt Ph.D.	Chief Scientific Officer
7	Ms. Amy Flood	Chief Human Resources & Communications Officer
8	Ms. Monica Tellado	President of Emerging Markets
9	Mr. Roberto W. Vieira	President of Oncology
10	Mr. Justin Gunn M.D.	President of Endocrinology

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	BlackRock Inc	11,50%	1,07 Mrd. USD
2	Ingalls & Snyder LLC	7,34%	0,69 Mrd. USD
3	Renaissance Technologies Corp	4,87%	0,45 Mrd. USD
4	Vanguard Portfolio Management, LLC	4,67%	0,44 Mrd. USD
5	Vanguard Capital Management, LLC	3,86%	0,36 Mrd. USD
6	Parallel Advisors, LLC	3,67%	0,34 Mrd. USD
7	FMR Inc	3,09%	0,29 Mrd. USD
8	State Street Corp	3,03%	0,28 Mrd. USD
9	AQR Capital Management LLC	2,39%	0,22 Mrd. USD
10	Geode Capital Management, LLC	2,34%	0,22 Mrd. USD
11	First Trust Advisors L.P.	1,69%	0,16 Mrd. USD
12	TANG CAPITAL MANAGEMENT LLC	1,39%	0,13 Mrd. USD
13	UBS Group AG	1,27%	0,12 Mrd. USD
14	Dimensional Fund Advisors, Inc.	1,22%	0,11 Mrd. USD
15	Charles Schwab Investment Management Inc	1,07%	0,10 Mrd. USD
16	Morgan Stanley - Brokerage Accounts	1,05%	0,10 Mrd. USD
17	D. E. Shaw & Co LP	0,82%	0,08 Mrd. USD
18	HPM Partners LLC	0,74%	0,07 Mrd. USD
19	MPM Oncology Impact Management LP	0,71%	0,07 Mrd. USD
20	Northern Trust Corp	0,70%	0,07 Mrd. USD